A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self-administration.

BACKGROUND AND OBJECTIVES Limiting alcohol consumption may help prevent alcohol-mediated smoking relapse in heavy drinking smokers. This pilot study examined whether combining a nicotine patch with nicotine nasal spray has stronger attenuating effects on alcohol response and consumption than a nicotine patch alone. METHODS Twenty-two non-alcohol dependent heavy drinking smokers completed the double-blind cross-over, placebo-controlled study (21 mg nicotine patch + nicotine or placebo nasal spray). Six hours after 21 mg nicotine patch application, subjective and physiological responses to a priming drink (0.3 g/kg) were assessed, followed by two 1-hr alcohol self-administration periods, with possible consumption of up to 4 drinks per period (each 0.15 g/kg). Nasal spray (1 mg [active] or 0 mg [placebo] per dose) was administered 10 min prior to the priming dose and each self-administration period. RESULTS Active nasal spray did not increase serum nicotine levels, compared with placebo administration. The number of drinks consumed did not differ by the nasal spray conditions. However, positive subjective responses to the priming drink were lower in the active nasal spray condition than the placebo nasal spray condition. During the self-administration period, urge to drink was also lower in the active spray condition than the placebo condition. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE Augmenting the nicotine patch with nicotine nasal spray attenuated positive subjective alcohol response and craving and suggests that future studies should investigate whether these findings translate to a clinical setting.

[1]  Megan E. Piper,et al.  A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. , 2009, Archives of general psychiatry.

[2]  H. de Wit,et al.  Individual differences in the biphasic effects of ethanol. , 1998, Alcoholism, clinical and experimental research.

[3]  K. Fagerström,et al.  Clinical Pharmacokinetics of Nasal Nicotine Delivery , 1996, Clinical pharmacokinetics.

[4]  S. Shiffman,et al.  Does heightened affect make smoking cues more salient? , 2008, Journal of abnormal psychology.

[5]  J. Marrero,et al.  Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. , 2005, Journal of hepatology.

[6]  D. Hatsukami,et al.  Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.

[7]  D. Mant,et al.  Nicotine replacement therapy for smoking cessation. , 2004, The Cochrane database of systematic reviews.

[8]  K. Cummings,et al.  Alcohol consumption and quitting smoking in the International Tobacco Control (ITC) Four Country Survey. , 2009, Drug and alcohol dependence.

[9]  Rajita Sinha,et al.  Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis , 2002, Psychopharmacology.

[10]  S. O'Malley,et al.  Modeling the effect of alcohol on smoking lapse behavior , 2006, Psychopharmacology.

[11]  S. Shiffman,et al.  Situational correlates of abstinence self-efficacy. , 2005, Journal of abnormal psychology.

[12]  Dependence Update Panel,et al.  A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. , 2008, American journal of preventive medicine.

[13]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[14]  C. la Vecchia,et al.  Cancer Risk Associated with Alcohol and Tobacco Use: Focus on Upper Aero-digestive Tract and Liver , 2006, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[15]  S. Shiffman,et al.  Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment. , 2007, Drug and alcohol dependence.

[16]  Clinical Practice Guideline for Treating Tobacco se and Dependence : 2008 Update , 2022 .

[17]  N. Benowitz,et al.  Bioavailability and absorption kinetics of nicotine following application of a transdermal system. , 1993, British journal of clinical pharmacology.

[18]  R. Harris,et al.  Nicotine addiction and comorbidity with alcohol abuse and mental illness , 2005, Nature Neuroscience.

[19]  J. Steinbach,et al.  Nicotine is Highly Effective at Producing Desensitization of Rat α4β2 Neuronal Nicotinic Receptors , 2003 .

[20]  Maristela Monteiro,et al.  AUDIT - The alcohol use disorders identification test: guidelines for use in primary care. , 2001 .

[21]  M. Picciotto,et al.  Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers , 2009, Biological Psychiatry.

[22]  C. Lerman,et al.  Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[23]  J. Henningfield,et al.  Combination Nicotine Replacement Therapy for Smoking Cessation , 2001, CNS drugs.

[24]  Ashley Acheson,et al.  Differential effects of nicotine on alcohol consumption in men and women , 2006, Psychopharmacology.

[25]  L. Bierut,et al.  Co-Occurring Risk Factors for Alcohol Dependence and Habitual Smoking , 2006, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[26]  L. Melton,et al.  Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. , 1996, JAMA.

[27]  T. Baker,et al.  The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. , 2011, Journal of consulting and clinical psychology.

[28]  M. Litt,et al.  Smoking cessation during alcohol treatment: a randomized trial of combination nicotine patch plus nicotine gum. , 2009, Addiction.

[29]  M. Fiore,et al.  Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. , 2009, Archives of internal medicine.

[30]  M. Earleywine,et al.  Development and validation of the Biphasic Alcohol Effects Scale. , 1993, Alcoholism, clinical and experimental research.

[31]  H. de Wit,et al.  Mecamylamine and ethanol preference in healthy volunteers. , 2005, Alcoholism, clinical and experimental research.

[32]  L. Cox,et al.  Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[33]  Suchitra Krishnan-Sarin,et al.  Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration , 2008, Psychopharmacology.

[34]  D. Krahn,et al.  Development and initial validation of a measure of drinking urges in abstinent alcoholics. , 1995, Alcoholism, clinical and experimental research.

[35]  S. O'Malley,et al.  Smoking status as a clinical indicator for alcohol misuse in US adults. , 2007, Archives of internal medicine.

[36]  The subjective and reinforcing effects of visual and olfactory stimuli in alcohol drinking. , 2003, Experimental and clinical psychopharmacology.

[37]  J. Steinbach,et al.  Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors. , 2003, The Journal of physiology.